Alliance Global Partners Starts Eyegate Pharmaceuticals (EYEG) at Buy
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.50 -0.06%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Alliance Global Partners analyst Ben Haynor initiates coverage on Eyegate Pharmaceuticals (NASDAQ: EYEG) with a Buy rating and a price target of $9.50.
For an analyst ratings summary and ratings history on Eyegate Pharmaceuticals click here. For more ratings news on Eyegate Pharmaceuticals click here.
Shares of Eyegate Pharmaceuticals closed at $4.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- TD Cowen Assumes Maze Therapeutics (MAZE) at Buy
- TD Cowen Assumes Immunocore Holdings (IMCR) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
